Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Exp Neurol. 2014 Nov 26;264:1–7. doi: 10.1016/j.expneurol.2014.11.007

Figure 5.

Figure 5

miR-181a antagomir increases anti-apoptotic protein BCL2 and apoptosis inhibitor XIAP with IV post-stroke treatment. A. Western blots showing no significant change in GRP78 protein level, but increased BCL2 and XIAP protein levels 24 hours after MCAO with post-treatment. For comparison the immunofluorescence intensities of Western blots were normalized to MM control in each group in the bar graphs. N= 7 (GRP78), N=6 (BCL-2), N=10 (XIAP), * p<0.05 vs MM control. B. Representative images showing increased XIAP staining (green). MM: mismatched control.